Citation Impact
Citing Papers
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
2012 Standout
Complement and its role in innate and adaptive immune responses
2009 Standout
The lipid composition and biochemistry of freshwater fish
1987 Standout
Aloe vera leaf gel: a review update
1999 Standout
Free Radicals as Mediators of Tissue Injury and Disease
1993 Standout
BGP-15, a nicotinic amidoxime derivate protecting heart from ischemia reperfusion injury through modulation of poly(ADP-ribose) polymerase
2000
Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes
2007 Standout
Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance
2003 Standout
The Therapeutic Potential of Poly(ADP-Ribose) Polymerase Inhibitors
2002 Standout
The biology and pharmacology of PGD2
1988
Lack of significant effects of superoxide dismutase and catalase on development of reperfusion arrhythmias
1991
Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2012 Standout
Cytokines, Inflammation, and Pain
2007 Standout
A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation
1995 Standout
Proinflammatory Cytokines
2000 Standout
Interleukin-1 enhances pain reflexes. Mediation through increased prostaglandin E2 levels
1988
Sulfonylureas and cardiovascular effects: from experimental data to clinical use. Available data in humans and clinical applications
2003
Diagnostic criteria and classification of mastocytosis: a consensus proposal
2001 Standout
Anaphylatoxins: C3a and C5a
1978
Leukotrienes: A novel group of compounds including SRS-A
1981 StandoutNobel
Acetyl glyceryl ether phosphorylcholine (AGEPC). A putative mediator of cardiac anaphylaxis in the guinea pig.
1984
Coronary vasoconstriction and PGI2 release by leukotrienes in isolated guinea pig hearts
1981
Airway Effects of Slow Reacting Substance, Prostaglandin F2αand Histamine in the Guinea‐Pig
1975
Contractile activities of leukotrienes C4 and D4 on vascular strips from rabbits
1981
9,11-Epoxyiminoprosta-5,13-dienoic acid is a thromboxane A2 antagonist in human platelets
1978 Nature
EFFECTS OF MODULATORS OF ARACHIDONIC ACID METABOLISM ON THE SYNTHESIS AND RELEASE OF SLOW‐REACTING SUBSTANCE OF ANAPHYLAXIS
1979
Leukotrienes: Biosynthesis, Metabolism, and Analysis
1985
Prostaglandins and cardiac anaphylaxis
1976
Leukotrienes: Mediators of Immediate Hypersensitivity Reactions and Inflammation
1983 StandoutScienceNobel
Low dose aspirin and inhibition of thromboxane B2 production in healthy subjects
1980
Prooxidant States and Tumor Promotion
1985 StandoutScience
Deleterious effects of oxygen radicals in ischemia/reperfusion. Resolved and unresolved issues.
1989
Intervention with epinephrine in hypotension associated with mastocytosis
1983
The leukotrienes: a new group of biologically active compounds
1981 StandoutNobel
State of adrenergic and cholinergic nervous structures of the rabbit heart after sensitization and anaphylactic shock
1983
Leukotriene D: a slow reacting substance from rat basophilic leukemia cells.
1980 StandoutNobel
Precursor role of arachidonic acid in release of slow reacting substance from rat basophilic leukemia cells.
1977
Putative mechanism of hypotensive action of platelet-activating factor in dogs.
1992 StandoutNobel
Vanilloid (Capsaicin) Receptors and Mechanisms
1999 Standout
Pharmacological control of prostaglandin and thromboxane release from macrophages
1978 Nature
The leukotrienes: a new group of biologically active compounds including SRS-A
1980 StandoutNobel
Formation of leukotriene C4-like material by rat brain tissue
1984
Arachidonic acid metabolism in polymorphonuclear leukocytes
1979 StandoutNobel
Effects of Indomethacin on the Guinea-Pig Pulmonary Response to Intravenous Leukotrienes C4 and D4
1983 StandoutNobel
Biological activities of complement-derived peptides
1987
Photobiomodulation: lasers vs. light emitting diodes?
2018 Standout
Nomenclature for thromboxanes
1978 StandoutNobel
RELEASE OF MEDIATORS OF ANAPHYLAXIS: INHIBITION OF PROSTAGLANDIN SYNTHESIS AND THE MODIFICATION OF RELEASE OF SLOW REACTING SUBSTANCE OF ANAPHYLAXIS AND HISTAMINE
1978
The scavenger cell pathway for lipoprotein degradation: Specificity of the binding site that mediates the uptake of negatively‐charged LDL by macrophages
1980 StandoutNobel
Leukotriene C: a slow-reacting substance from murine mastocytoma cells.
1979 StandoutNobel
Structural requirement for the action of leukotriene B4 on the guinea-pig lung:Importance of double bond geometry in the 6, 8, 10-triene unit
1981 StandoutNobel
Chemical studies on slow reacting substances/leukotrienes
1982 StandoutNobel
THE ACTIONS OF LEUKOTRIENES C4 AND D4 ON GUINEA‐PIG ISOLATED HEARTS
1982
Total synthesis of a potent thromboxane A2 antagonist
1990 StandoutNobel
Characterization of furosemide-induced activation of the renal prostaglandin system
1979
PHOSPHOLIPASE A2 ACTIVITY OF GUINEA‐PIG ISOLATED PERFUSED LUNGS: STIMULATION, AND INHIBITION BY ANTI‐INFLAMMATORY STEROIDS
1978 StandoutNobel
Leukotrienes and Slow Reacting Substance of Anaphylaxis (SRS‐A)
1980 StandoutNobel
Leukotrienes and Lipoxins: Structures, Biosynthesis, and Biological Effects
1987 StandoutScienceNobel
Leukotrienes: A Novel Group of Biologically Active Compounds
1982 StandoutNobel
International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes.
1994 Standout
Anaphylactic shock in monkeys passively sensitized with human reaginic serum
1981
Prostaglandins and Thromboxanes
1978 StandoutNobel
Prostaglandins, their intermediates and precursors: Cardiovascular actions and regulatory roles in normal and abnormal circulatory systems
1979 StandoutNobel
Renal Syndromes Associated with Nonsteroidal Antiinflammatory Drugs
1984 Standout
Leukotriene C4 affects pulmonary and cardiovascular dynamics in monkey
1982 StandoutNatureNobel
From slow reacting substance of anaphylaxis (SRS-A) to leukotriene D4 (LTD4)
1980
Effects of exogenous arachidonic, eicosapentaenoic, and docosahexaenoic acids on the generation of 5-lipoxygenase pathway products by ionophore-activated human neutrophils.
1984 StandoutNobel
Selective Cumulative Inhibition of Platelet Thromboxane Production by Low-dose Aspirin in Healthy Subjects
1982 Standout
Synthesis of a stable analog of thromboxane A2 with methylene replacing the 9,11-bridging oxygen
1980 StandoutNobel
The biology of platelet-derived growth factor
1986 Standout
Interleukin-1 and interleukin-1 antagonism
1991 Standout
Leukotriene A. Isolation from human polymorphonuclear leukocytes.
1980 StandoutNobel
Release of prostaglandins E and F in an algogenic reaction and its inhibition
1980 Standout
Effects of Disturbed Flow on Vascular Endothelium: Pathophysiological Basis and Clinical Perspectives
2011 Standout
Calmodulin Plays a Pivotal Role in Cellular Regulation
1980 StandoutScience
Transformation of arachidonic acid and prostaglandin endoperoxides by the guinea pig heart. Formation of RCS and prostacyclin
1978 StandoutNobel
Prostaglandin and thromboxane synthesis in a pure macrophage population and the inhibition, by E‐type prostaglandins, of chemiluminescence
1978
Works of W. Bernauer being referenced
Differential effects of superoxide dismutase on high energy phosphates, creatine kinase release, and arrhythmias during post-ischaemic reperfusion in isolated rat hearts
1988
Concerning the effect of the K+ channel blocking agent glibenclamide on ischaemic and reperfusion arrhythmias
1997
Catecholamine release during anaphylactic shock in guinea pigs
1971
Studies on Heart Anaphylaxis
1969
Release of prostaglandins, a prostaglandin metabolite, slow-reacting substance and histamine from anaphylactic lungs, and its modification by catecholamines
1974
Studies on heart anaphylaxis. V. Cross-desensitisation between antigen, anaphylatoxin, and compound 48-80 in the guinea-pig papillary muscle.
1972
The Role of Catecholamines in Mepyramine Resistance of Anaphylactic Bronchospasm <i>in vitro</i>
1970
Radioimmunological determination of thromboxane release in cardiac anaphylaxis
1977
Effect of antiarrhythmic drugs on the postischaemic metabolic recovery of isolated rat hearts.
1992
Release of 15-keto-13, 14-dihydro-thromboxane B2 and prostaglandin D2 during anaphylaxis as measured by radioimmunoassay
1978
Studies on Heart Anaphylaxis
1972
Investigations on the Catecholamine Release in Anaphylactic, Anaphylatoxin, and Histamine Shock of Guinea Pigs
1973
Prostaglandin, slow-reacting substance, and histamine release from anaphylactic guinea-pig hearts, and its pharmacological modification
1975
Comparison of the antilethal, broncholytic, and antiemphysematous activities of mepyramine in anaphylactic, histamine, and anaphylatoxin shock of guinea-pigs.
1969
Pharmacological modification of thromboxane and prostaglandin release in cardiac anaphylaxis
1978